Clinical trial
Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or…
NCT00019773 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019773 |
|---|---|
| Title | Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer |
| Official title | Pilot Study of Oxaliplatin in Combination With Capecitabine in Adult Cancer Patients |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Carcinoma of the Appendix, Colorectal Cancer, Small Intestine Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, oxaliplatin |
| Start date | Jul 1, 1999 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 29, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: